Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial

BACKGROUND: Stable angina pectoris (SAP) currently seriously threatens the health of humans, and mortality is continuously rising. Current treatment strategies mainly include pharmaceutical therapy and revascularization. In China, Buyang Huanwu granules (BYHW) and Naoxintong capsules (NXT) have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Xu, Yuhan, Zhang, Ling, Huang, Shuwei, Dou, Liping, Yang, Jiehong, Fu, Wei, Zhou, Peng, Wan, Haitong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780317/
https://www.ncbi.nlm.nih.gov/pubmed/35062988
http://dx.doi.org/10.1186/s13063-021-05914-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780317/
https://www.ncbi.nlm.nih.gov/pubmed/35062988
http://dx.doi.org/10.1186/s13063-021-05914-1

Ejemplares similares